188宝金博页面版

Schnell et al. Cardiovasc Diabetol (2017) 16:135 DOI 10.1186/s12933-017-0616-5CORRECTIONCorrection to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study GroupOliver Schnell 1* , Eberhard Standl 1 , Doina Catrinoiu 2 , Stefano Genovese 3 , Nebojsa Lalic 4 , Jan Skra 5 , Paul Valensi 6 , Dario Rahelic 7 and Antonio Ceriello 8,9© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Correction to: Cardiovasc Diabetol (2017) 16:35 DOI 10.1186/s12933?017?0508?8Following publication of the original article [1], author Antonio Ceriello requested that a correction be pub-lished in relation to his af f i liations. His correct af f i liations have been updated in this erratum. Th is correction is very important for the correct assignment of funds to his Institutions.Author details1 Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany. 2 Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd, No. 145, 900591 Constanta, Roma?nia. 3 Diabetes and Metabolic Disease Unit, IRCCS MultiMedica, Via Milanese 300, 20099 Sesto San Giovanni, MI, Italy. 4 Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, Uni?versity of Belgrade, Dr Subotica 13, Belgrade 11000, Serbia. 5 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U Nemocnice 1, 128 08 Prague 2, Czech Republic. 6 Department of Endocrinology Diabetol?ogy Nutrition, CINFO, CRNH?IdF, Jean VERDIER Hospital, Paris 13 University, Avenue du 14 Juillet, 93140 Bondy, France. 7 Diabetes and Metabolic Disorders, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia. 8 Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Cen?tro de Investigacion Biomèdica en Red de Diabetes y Enfermedades Metaboli?cas Asociadas (CIBERDEM), Barcelona, Spain. 9 Department of Cardiovascular and Metabolic Diseases, IRCCS Multimedica, Sesto San Giovanni, Milan, Italy. Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in pub?lished maps and institutional af f i liations.Received: 6 October 2017 Accepted: 6 October 2017Reference 1. Schnell O, Stand E, Catrinoiu D, Genovese S, Lalic N, Skra J, Valensi P, Rahelic D, Ceriello A. Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group. Cardiovasc Diabetol. 2017;16:35. doi:10.1186/s12933?017?0508?8.Open AccessCardiovascular Diabetology*Correspondence: oliver.schnell@lrz.uni?muenchen.de 1 Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764 Neuherberg, GermanyFull list of author information is available at the end of the articleThe online version of the original article can be found under doi:10.1186/s12933?017?0508?8.